Evaluating Precision Medicine in Advanced Prostate Cancer

Dr. Rupert Ecker co-authored a review on genomic and phenotypic biomarkers guiding precision medicine in advanced prostate cancer, highlighting strategies for diagnosis, prognosis, and treatment prediction.